Navigation Links
Relief from Menopause Symptoms Short-lived for Prempro Women Suffering from Cancers
Date:7/10/2012

CRESSKILL, N.J., July 10, 2012 /PRNewswire/ -- Prempro promised women relief from menopause symptoms, but the relief was short-lived for the estimated 10,000 plaintiffs who developed breast cancer after taking the drug. Pfizer, which purchased Prempro's original manufacturer, Wyeth, has set aside $330 million to settle 4,000 remaining suits after already settling some 6,000 suits for $896 million. The settlements come after six years of trials in which courts found Pfizer and Wyeth guilty of "wanton and reckless" behavior (http://www.drdach.com/Prempro_Dangerous.html). As it may take months, if not years, for the settlements to be disbursed, RD Legal Funding, LLC ("RD Legal") is offering the plaintiffs, and their attorneys, legal settlement funding as soon as settlement amounts have been finalized.

(Logo: http://photos.prnewswire.com/prnh/20110803/NY45278LOGO )

Prempro became the most prescribed drug in the Unites States despite conflicting studies, some claiming the drugs' health benefits and others warning of significant health risks. Prescribed originally to reduce menopausal side effects including hot flashes, Prempro is a Hormone Replacement Therapy (HRT) combining an existing Wyeth product called Premarin (conjugated equine estrogen: estrogen derived from the urine of pregnant female horses), and Provera (medroxyprogesterone acetate, a powerful synthetic progesterone).

At least 6 million women used Prempro. Sales reached $2 billion a year in 2001 before a federal study reported in 2002 that Prempro increased the incidence of breast cancer by 26 percent, heart attack by 29 percent, stroke by 41 percent, and blood clots in the legs and veins by 105 percent. A number of other adverse health consequences including ovarian and gall bladder ca
'/>"/>

SOURCE RD Legal Funding, LLC
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Ameritox Files Amended Complaint Against Millennium Laboratories For Injunctive Relief, Declaratory Relief and Damages
2. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
3. Patient Advocate Foundation Announces New Co-Pay Relief (CPR) Offerings for Patients Facing Health Issues Due to Electrolyte Imbalance
4. Direct Relief Delivers Hurricane Packs As FEMA Urges Preparedness
5. MLB All-Star Pitcher CC Sabathia Issues Fast Relief Challenge to Generate Donations for the American Red Cross
6. Abbott, The Abbott Fund And Direct Relief International Reach Key HIV Testing Milestones: 20 Million Tests Provided Over 10 Years, And More Than 150,000 HIV Cases Prevented In Children
7. NAMS Journal Menopause Reflects on the WHI 10 Years Later
8. Clinical Trial at Evergreen Healthcare Shows Intestinal Gel Reduces Symptoms of Advanced Parkinsons Disease
9. Data from Study of Elderly Depressed Patients are Reported for Investigational Compound Lu AA21004 on Symptoms of Major Depressive Disorder (MDD)
10. Sorbent Therapeutics CLP1001 Improves Heart Failure Symptoms In Phase 2 Clinical Study
11. Soy-Based S-equol Supplement Reduces Hot Flash Frequency, Muscle And Joint Pain In U.S. Postmenopausal Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... BERKELEY, Calif. , July 29, 2015 ... the Daiichi Sankyo Group, announced today that The ... trial results demonstrating that the investigational drug, PLX3397, an ... most patients with tenosynovial giant cell tumor (TGCT), a ... sheath. Following phase 1 dose-escalation, which evaluated ...
(Date:7/29/2015)... Calif. and CAMBRIDGE, Mass. ... Inc. (NASDAQ: ISIS ), the leader in ... subsidiary, announced today that The New England ... a Phase 2 clinical study evaluating volanesorsen (formerly ... to severely high triglycerides. This publication follows the ...
(Date:7/29/2015)... Calif., July 29, 2015  STAAR Surgical Company (NASDAQ: ... lenses and delivery systems for the eye today reported financial ... Second Quarter Overview , Net Sales of ... , Unfavorable Currency Impact of $2.1 Million from the Weakening ... EMEA and 13% in China , APAC Sales Down ...
Breaking Medicine Technology:Daiichi Sankyo and Plexxikon Announce Study Published in NEJM Demonstrates PLX3397 Induced Prolonged Tumor Regression in Tenosynovial Giant Cell Tumor (TGCT) in Most Patients 2Daiichi Sankyo and Plexxikon Announce Study Published in NEJM Demonstrates PLX3397 Induced Prolonged Tumor Regression in Tenosynovial Giant Cell Tumor (TGCT) in Most Patients 3Daiichi Sankyo and Plexxikon Announce Study Published in NEJM Demonstrates PLX3397 Induced Prolonged Tumor Regression in Tenosynovial Giant Cell Tumor (TGCT) in Most Patients 4Daiichi Sankyo and Plexxikon Announce Study Published in NEJM Demonstrates PLX3397 Induced Prolonged Tumor Regression in Tenosynovial Giant Cell Tumor (TGCT) in Most Patients 5Positive Clinical Data From Volanesorsen Published in the New England Journal of Medicine 2Positive Clinical Data From Volanesorsen Published in the New England Journal of Medicine 3Positive Clinical Data From Volanesorsen Published in the New England Journal of Medicine 4Positive Clinical Data From Volanesorsen Published in the New England Journal of Medicine 5Positive Clinical Data From Volanesorsen Published in the New England Journal of Medicine 6Positive Clinical Data From Volanesorsen Published in the New England Journal of Medicine 7STAAR Surgical Reports Second Quarter 2015 Results 2STAAR Surgical Reports Second Quarter 2015 Results 3STAAR Surgical Reports Second Quarter 2015 Results 4STAAR Surgical Reports Second Quarter 2015 Results 5STAAR Surgical Reports Second Quarter 2015 Results 6STAAR Surgical Reports Second Quarter 2015 Results 7STAAR Surgical Reports Second Quarter 2015 Results 8STAAR Surgical Reports Second Quarter 2015 Results 9STAAR Surgical Reports Second Quarter 2015 Results 10STAAR Surgical Reports Second Quarter 2015 Results 11STAAR Surgical Reports Second Quarter 2015 Results 12STAAR Surgical Reports Second Quarter 2015 Results 13STAAR Surgical Reports Second Quarter 2015 Results 14STAAR Surgical Reports Second Quarter 2015 Results 15STAAR Surgical Reports Second Quarter 2015 Results 16STAAR Surgical Reports Second Quarter 2015 Results 17STAAR Surgical Reports Second Quarter 2015 Results 18STAAR Surgical Reports Second Quarter 2015 Results 19STAAR Surgical Reports Second Quarter 2015 Results 20STAAR Surgical Reports Second Quarter 2015 Results 21STAAR Surgical Reports Second Quarter 2015 Results 22STAAR Surgical Reports Second Quarter 2015 Results 23STAAR Surgical Reports Second Quarter 2015 Results 24
... Alere Inc. (NYSE: ALR ), a global ... home through the merger of rapid diagnostics and health management, today ... Financial results for the fourth quarter of 2010: ... quarter of 2010, compared to $546.2 million for the fourth quarter ...
... Feb. 16, 2011 OHK Medical Devices, Inc. announced ... U.S. physician business of Henry Schein Inc. (Nasdaq: ... products and services to office-based dental, medical and veterinary ... U.S. alternate care market. HemaClear is the first and ...
Cached Medicine Technology:Alere Inc. Announces Fourth Quarter 2010 Results 2Alere Inc. Announces Fourth Quarter 2010 Results 3Alere Inc. Announces Fourth Quarter 2010 Results 4Alere Inc. Announces Fourth Quarter 2010 Results 5Alere Inc. Announces Fourth Quarter 2010 Results 6Alere Inc. Announces Fourth Quarter 2010 Results 7Alere Inc. Announces Fourth Quarter 2010 Results 8Alere Inc. Announces Fourth Quarter 2010 Results 9Alere Inc. Announces Fourth Quarter 2010 Results 10Alere Inc. Announces Fourth Quarter 2010 Results 11Alere Inc. Announces Fourth Quarter 2010 Results 12Alere Inc. Announces Fourth Quarter 2010 Results 13Alere Inc. Announces Fourth Quarter 2010 Results 14Alere Inc. Announces Fourth Quarter 2010 Results 15Alere Inc. Announces Fourth Quarter 2010 Results 16Alere Inc. Announces Fourth Quarter 2010 Results 17Alere Inc. Announces Fourth Quarter 2010 Results 18Alere Inc. Announces Fourth Quarter 2010 Results 19OHK Medical Devices Selects Henry Schein as Exclusive Distributor of HemaClear® 2OHK Medical Devices Selects Henry Schein as Exclusive Distributor of HemaClear® 3
(Date:7/29/2015)... , ... July 29, 2015 , ... ... increasingly aware of the impact drinking and substance abuse is having on lost ... loss is tagged in the billions per year. [1] Will Wesch, Director of ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... health inequities. Since 2012, Massachusetts law has provided legal protections against discrimination on ... the law does not protect against discrimination based on gender identity in places ...
(Date:7/29/2015)... ... ... According to the The Media Post on July 9th teenagers ... medicinal use are more likely to abuse the substance. A recent study conducted by ... beneficial are more apt to use the substance, as opposed to their peers who ...
(Date:7/29/2015)... , ... July 29, 2015 , ... Potomac Pilates, an ... changing its name to Rock the Reformer ® by Potomac Pilates. On Thursday, ... http://www.RockTheReformer.com . Rock the Reformer ® by Potomac Pilates will continue to offer the ...
(Date:7/29/2015)... ... July 29, 2015 , ... Join Luz Delia Gerber and ... believes that Well-Being begins with understanding how the body actually works. A state of ... within. Guests will receive tips on how to forge this new relationship with their ...
Breaking Medicine News(10 mins):Health News:Workplace Trouble: Survey Reveals Sharp Escalation in Restaurant/Food Service Employee Drug Abuse 2Health News:Workplace Trouble: Survey Reveals Sharp Escalation in Restaurant/Food Service Employee Drug Abuse 3Health News:Fenway Health Researcher: Legal Protections in Public Settings are a Critical Public Health Issue for Transgender and Gender-Nonconforming People 2Health News:Fenway Health Researcher: Legal Protections in Public Settings are a Critical Public Health Issue for Transgender and Gender-Nonconforming People 3Health News:New Study Reveals Teens Use Marijuana More in States Where Marijuana Is Legalized 2Health News:New Study Reveals Teens Use Marijuana More in States Where Marijuana Is Legalized 3Health News:Same Great Pilates Studio, New Brand - Rock the Reformer 2Health News:Pampering and Empowerment Abound at Final Event in Luz Delia Gerber’s Book Unveiling 2
... HACKETTSTOWN, NJ (March 20, 2008) V Daily consumption of ... sterols and cocoa flavanols may affect cardiovascular risk by ... to a new study published in the Journal of ... from the University of Illinois and Mars, Incorporated found ...
... found standard mound might raise risk of stress injuries ... of a pitcher,s mound can influence the risk of ... by the head team physician for the Milwaukee Brewers. ... Baseball organizations and Milwaukee-area NCAA Division I-A college teams. ...
... JOSEPH, Mich., March 26 GeneGo, Inc., ... the release of MetaMiner,Cystic Fibrosis, a first ... to help advance drug discovery for cystic ... tool will,provide the cystic fibrosis research community ...
... /Xinhua-PRNewswire-FirstCall/ -- China Yingxia,International, Inc. (OTC Bulletin ... industry engaged in the development, manufacture and,distribution ... care products in China, today announced that ... Yingxia, will host a conference call to ...
... 26 Three years ago, Leverage,Life began offering an ... Hotline program has proven to be a much-needed,benefit for ... that by 2012 the growth of the,workforce will be ... decline by nearly,three million, or 6.8%, and workers over ...
... Caregivers Say Their Children Help Care for Loved Ones With ... ... from the third annual,Alzheimer,s Foundation of America (AFA) ICAN: Investigating Caregivers,Attitudes ... Most "sandwich caregivers" -- the parents or guardians of,children under 21 ...
Cached Medicine News:Health News:New study suggests that specially-formulated 2Health News:New study suggests that specially-formulated 3Health News:Height of Pitcher's Mound Can Strain Shoulders 2Health News:GeneGo Rolls out MetaMiner Cystic Fibrosis - the First Disease-Specific Software Platform to Advance Drug Discovery 2Health News:GeneGo Rolls out MetaMiner Cystic Fibrosis - the First Disease-Specific Software Platform to Advance Drug Discovery 3Health News:China Yingxia International Announces 2007 Fourth Quarter and Full Year Financial Results Conference Call 2Health News:Leverage Life's Homework Hotline Is a Resounding Success! 2Health News:New Alzheimer's Disease Survey Reveals Children of Sandwich Caregivers Assist With Loved Ones' Care 2Health News:New Alzheimer's Disease Survey Reveals Children of Sandwich Caregivers Assist With Loved Ones' Care 3Health News:New Alzheimer's Disease Survey Reveals Children of Sandwich Caregivers Assist With Loved Ones' Care 4Health News:New Alzheimer's Disease Survey Reveals Children of Sandwich Caregivers Assist With Loved Ones' Care 5
... Ultra Q is a hospital grade Nd: ... with a precise, reliable means for performing ... The system can be used for the ... the capsule (posterior capsulotomy), and closed-angle glaucoma ...
... is a high-end, mobile ultrasound imaging system. ... a tremendous amount of processing power for ... Ultrasonix imaging systems provide excellent image ... B/M, Pulsed Doppler, Color Doppler Color Angio, ...
Protects the eye during or after surgery or trauma. 8mm diameter, lint free keeps cornea moist. Protects retina from operating microscope light rays....
... segment surgical procedures. For dissection of vitreoretinal ... luer lock tubing set is attached to ... - .02in (.50mm); OD - .06in (1.5mm) ... viscoelastic fluids. 30G (.30mm) tip, flattened. Angled ...
Medicine Products: